KeyBank National Association
AMED

KeyBank National Association’s Amedisys AMED Stock Holding History

KeyBank National Association’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-800
Closed -$212K – 1058
2021
Q1 		$212K Hold
800
– – ﹤0.01% 1013
2020
Q4 		$235K Sell
800
-215
-21% -$55.1K ﹤0.01% 956
2020
Q3 		$240K Buy
+1,015
New +$231K ﹤0.01% 898

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

KeyBank National Association's AMED Position: Q2 2021 in Review

KeyBank National Association sold out of Amedisys (AMED) in Q2 2021, closing a stake of 800 shares — an estimated $212K sold.

KeyBank National Association first reported a position in AMED in Q3 2020 and held it in 3 quarters. The position peaked at $240K in Q3 2020. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • KeyBank National Association reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • KeyBank National Association sold 800 Amedisys shares in Q2 2021, an estimated $212K.
  • KeyBank National Association first reported a position in Amedisys in Q3 2020 and held it in 3 quarters.
  • KeyBank National Association's Amedisys position peaked at $240K in Q3 2020.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on KeyBank National Association's 13F filing for Q2 2021, filed 12 Aug 2021.